| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $435,937 ) |
| | 2024 | 2024 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 114 STREET AND 89 AVENUE | EDMONTON | AB | | | CAN | R01DK137209 | Mechanisms of Islet Failure in CF | 000 | 1 | NIH | 9/19/2024 | $437,156 |
| | 2024 | 2023 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 114 STREET AND 89 AVENUE | EDMONTON | AB | | | CAN | R01AI150944 | Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria. | 000 | 4 | NIH | 4/11/2024 | $0 |
| | 2024 | 2023 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 114 STREET AND 89 AVENUE | EDMONTON | AB | | | CAN | R21HL161626 | Wearable Electrostrictive Row-Column Ultrasound Arrays for Longitudinal Echocardiography | 000 | 2 | NIH | 4/2/2024 | $0 |
| | 2024 | 2022 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 114 STREET AND 89 AVENUE | EDMONTON | AB | | | CAN | R21EY033078 | High Frequency Wearable and Transparent Electrostrictive Row-Column Arrays for Whole Brain Functional Imaging | 000 | 2 | NIH | 1/17/2024 | $0 |
| | 2024 | 2021 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 114 STREET AND 89 AVENUE | EDMONTON | AB | | | CAN | R01AI118842 | Role of CD22 in the Germinal Center Reaction | 000 | 5 | NIH | 5/16/2024 | $0 |
| | 2024 | 2021 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 114 STREET AND 89 AVENUE | EDMONTON | AB | | | CAN | U01DK120447 | Linking islet cell function and identity from in vitro to in situ | 000 | 4 | NIH | 4/1/2024 | -$1,219 |
|
| Issue Date FY: 2023 ( Subtotal = $469,505 ) |
| | 2023 | 2023 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 114 STREET AND 89 AVENUE | EDMONTON | AB | | | CAN | R21HL161626 | Wearable Electrostrictive Row-Column Ultrasound Arrays for Longitudinal Echocardiography | 000 | 2 | NIH | 4/27/2023 | $135,000 |
| | 2023 | 2023 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 114 STREET AND 89 AVENUE | EDMONTON | AB | | | CAN | R01AI150944 | Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria. | 000 | 4 | NIH | 3/28/2023 | $334,505 |
| | 2023 | 2021 | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA | 114 STREET AND 89 AVENUE | EDMONTON | AB | | | CAN | R21CA261833 | Treatment-specific genetic risk scores for late effects prediction in childhood,adolescent, and young adult cancer survivors | 000 | 1 | NIH | 5/12/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $403,536 ) |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R21EY033078 | High Frequency Wearable and Transparent Electrostrictive Row-Column Arrays for Whole Brain Functional Imaging | 000 | 2 | NIH | 9/6/2022 | $162,000 |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R01AI150944 | Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria. | 000 | 3 | NIH | 3/3/2022 | $334,505 |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R21HL161626 | Wearable Electrostrictive Row-Column Ultrasound Arrays for Longitudinal Echocardiography | 001 | 1 | NIH | 6/11/2022 | $1,139 |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R21HL161626 | Wearable Electrostrictive Row-Column Ultrasound Arrays for Longitudinal Echocardiography | 000 | 1 | NIH | 4/17/2022 | $160,861 |
| | 2022 | 2021 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | U01DK120447 | Linking islet cell function and identity from in vitro to in situ | 000 | 4 | NIH | 12/10/2021 | $0 |
| | 2022 | 2021 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R21CA261833 | Treatment-specific genetic risk scores for late effects prediction in childhood,adolescent, and young adult cancer survivors | 001 | 1 | NIH | 9/12/2022 | -$256,537 |
| | 2022 | 2021 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R21CA261833 | Treatment-specific genetic risk scores for late effects prediction in childhood,adolescent, and young adult cancer survivors | 000 | 1 | NIH | 11/8/2021 | $0 |
| | 2022 | 2020 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R01NS047567 | DIFFERING NEURONAL MECHANISMS MEDIATING LOCOMOTION AND SPASMS AFTER SPINAL CORD INJURY | 000 | 15 | NIH | 3/21/2022 | $0 |
| | 2022 | 2017 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R01AG008235 | Longitudinal Study of Cognitive Aging | 000 | 26 | NIH | 9/23/2022 | $1,568 |
|
| Issue Date FY: 2021 ( Subtotal = $1,877,735 ) |
| | 2021 | 2021 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R21EY033078 | High Frequency Wearable and Transparent Electrostrictive Row-Column Arrays for Whole Brain Functional Imaging | 000 | 1 | NIH | 9/16/2021 | $162,000 |
| | 2021 | 2021 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R21CA261833 | Treatment-specific genetic risk scores for late effects prediction in childhood,adolescent, and young adult cancer survivors | 000 | 1 | NIH | 8/30/2021 | $279,068 |
| | 2021 | 2021 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R01AI150944 | Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria. | 000 | 2 | NIH | 3/1/2021 | $491,792 |
| | 2021 | 2021 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | U01DK120447 | Linking islet cell function and identity from in vitro to in situ | 001 | 4 | NIH | 7/1/2021 | $744,534 |
| | 2021 | 2021 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R01AI118842 | Role of CD22 in the Germinal Center Reaction | 000 | 5 | NIH | 8/16/2021 | $270,000 |
| | 2021 | 2020 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | U01DK120447 | Linking islet cell function and identity from in vitro to in situ | 000 | 3 | NIH | 1/6/2021 | $0 |
| | 2021 | 2020 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R01NS047567 | DIFFERING NEURONAL MECHANISMS MEDIATING LOCOMOTION AND SPASMS AFTER SPINAL CORD INJURY | 000 | 15 | NIH | 5/17/2021 | $0 |
| | 2021 | 2017 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | | | CAN | R01AG008235 | Longitudinal Study of Cognitive Aging | 000 | 26 | NIH | 5/17/2021 | -$69,659 |
|
| Issue Date FY: 2020 ( Subtotal = $1,798,581 ) |
| | 2020 | 2020 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R01AI118842 | Role of CD22 in the Germinal Center Reaction | 000 | 4 | NIH | 8/17/2020 | $270,000 |
| | 2020 | 2020 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R01AI150944 | Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria. | 000 | 1 | NIH | 3/10/2020 | $490,848 |
| | 2020 | 2020 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R01NS047567 | DIFFERING NEURONAL MECHANISMS MEDIATING LOCOMOTION AND SPASMS AFTER SPINAL CORD INJURY | 001 | 15 | NIH | 2/11/2020 | $28,426 |
| | 2020 | 2020 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R01NS047567 | DIFFERING NEURONAL MECHANISMS MEDIATING LOCOMOTION AND SPASMS AFTER SPINAL CORD INJURY | 000 | 15 | NIH | 1/15/2020 | $255,843 |
| | 2020 | 2020 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | U01DK120447 | Linking islet cell function and identity from in vitro to in situ | 001 | 3 | NIH | 8/31/2020 | $753,464 |
| | 2020 | 2019 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | U01DK120447 | Linking islet cell function and identity from in vitro to in situ | 000 | 2 | NIH | 4/22/2020 | $0 |
| | 2020 | 2018 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R21AI128598 | Role of Siglec-10/G as a tumor suppressor in B-cells | 000 | 3 | NIH | 3/28/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,316,637 ) |
| | 2019 | 2019 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R01AI118842 | Role of CD22 in the Germinal Center Reaction | 000 | 3 | NIH | 8/29/2019 | $270,000 |
| | 2019 | 2019 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | U01DK120447 | Linking islet cell function and identity from in vitro to in situ | 001 | 2 | NIH | 9/5/2019 | $762,368 |
| | 2019 | 2019 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R01NS047567 | DIFFERING NEURONAL MECHANISMS MEDIATING LOCOMOTION AND SPASMS AFTER SPINAL CORD INJURY | 000 | 14 | NIH | 1/15/2019 | $284,269 |
| | 2019 | 2018 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | U01DK120447 | Linking islet cell function and identity from in vitro to in situ | 000 | 1 | NIH | 11/14/2018 | $0 |
| | 2019 | 2016 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R01AG008235 | Longitudinal Study of Cognitive Aging | 000 | 25 | NIH | 10/23/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,553,666 ) (Continued on the next page) |
| | 2018 | 2018 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R01AI118842 | Role of CD22 in the Germinal Center Reaction | 000 | 2 | NIH | 8/7/2018 | $270,000 |
| | 2018 | 2018 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | U01DK120447 | Linking islet cell function and identity from in vitro to in situ | 000 | 1 | NIH | 9/21/2018 | $776,917 |
| | 2018 | 2018 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 8625 112 ST NW SUITE 222 | EDMONTON | AB | T6G 1K8 | | CAN | R21AI128598 | Role of Siglec-10/G as a tumor suppressor in B-cells | 002 | 3 | NIH | 12/19/2017 | $108,000 |
| | 2018 | 2018 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 116 ST & 85 AVE | EDMONTON | AB | T6G 2R3 | | CAN | R01NS047567 | DIFFERING NEURONAL MECHANISMS MEDIATING LOCOMOTION AND SPASMS AFTER SPINAL CORD INJURY | 001 | 13 | NIH | 4/25/2018 | $28,426 |
| | 2018 | 2018 | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE | 8625 112 ST NW SUITE 222 | EDMONTON | AB | T6G 1K8 | | CAN | R01NS047567 | DIFFERING NEURONAL MECHANISMS MEDIATING LOCOMOTION AND SPASMS AFTER SPINAL CORD INJURY | 000 | 13 | NIH | 1/16/2018 | $255,843 |
|
